Dr Daiying Lu, MD | |
184 Tarrytown Rd, Manchester, NH 03103-2713 | |
(603) 627-1102 | |
Not Available |
Full Name | Dr Daiying Lu |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 20 Years |
Location | 184 Tarrytown Rd, Manchester, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912170614 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 221945 (Massachusetts) | Primary |
208600000X | Surgery | 14425 (New Hampshire) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Elliot Hospital | Manchester, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Elliot Professional Services | 6103727920 | 304 |
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A new JDRF-funded study shows that many of the genes known to play a role in type 1 diabetes (T1D) are expressed in pancreatic beta cells, suggesting that the cell responsible for producing insulin may be playing a part in its own destruction to lead to T1D.
Arizona State University and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases.
Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.
› Verified 5 days ago
Entity Name | Elliot Professional Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285627935 PECOS PAC ID: 6103727920 Enrollment ID: O20040115000634 |
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A new JDRF-funded study shows that many of the genes known to play a role in type 1 diabetes (T1D) are expressed in pancreatic beta cells, suggesting that the cell responsible for producing insulin may be playing a part in its own destruction to lead to T1D.
Arizona State University and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases.
Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daiying Lu, MD 21 Winding Rd, Bedford, NH 03110-5655 Ph: () - | Dr Daiying Lu, MD 184 Tarrytown Rd, Manchester, NH 03103-2713 Ph: (603) 627-1102 |
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A new JDRF-funded study shows that many of the genes known to play a role in type 1 diabetes (T1D) are expressed in pancreatic beta cells, suggesting that the cell responsible for producing insulin may be playing a part in its own destruction to lead to T1D.
Arizona State University and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases.
Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.
› Verified 5 days ago
Dr. Jeffrey Robert Harnsberger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2840 Fax: 603-695-2985 | |
Elena K Foster, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Queen City Ave, Manchester, NH 03101 Phone: 603-627-1102 Fax: 603-647-5524 | |
Elizabeth Sailhamer Soukup, M.D., M.M.SC. Surgery Medicare: Medicare Enrolled Practice Location: 1 Elliot Way, Manchester, NH 03103 Phone: 603-663-8393 Fax: 603-663-3493 | |
Jessica Niewodowski, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Queen City Ave, Manchester, NH 03101 Phone: 603-627-1102 | |
Kimberly Ann Licciardi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925 | |
Esthia Konstantinos Giakovis-sterling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 184 Tarrytown Rd, Manchester, NH 03103 Phone: 603-627-1102 Fax: 603-647-5524 | |
Edward P. Dalton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Elliot Breast Health Center, 275 Mammoth Road, Suite 1, Manchester, NH 03109 Phone: 603-668-3067 Fax: 603-668-0164 |